Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan

Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan

Hepatitis B virus vaccination and antiviral therapies reduce the risk of hepatocellular carcinoma (HCC). However, the lifetime healthcare expenditure involved in caring for HCC patients remains unclear. We examined the use and direct costs of healthcare services for a cohort of HCC patients to the h...

Full description

Bibliographic Details
Main Authors: Seng-Howe Nguang, Cheng-Kun Wu, Chih-Ming Liang, Wei-Chen Tai, Shih-Cheng Yang, Ming-Kun Ku, Lan-Ting Yuan, Jiunn-Wei Wang, Kuo-Lun Tseng, Tsung-Hsing Hung, Pin-I Hsu, Deng-Chyang Wu, Seng-Kee Chuah, Chien-Ning Hsu
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:International Journal of Environmental Research and Public Health
Subjects:
hepatocellular carcinoma
epidemiology
liver
cost
disease burden
healthcare
Taiwan
Online Access:https://www.mdpi.com/1660-4601/15/12/2655

Similar Items

Similar Items